ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP Last Month

November 25, 2011

Firm To Collaborate With R. W. Johnson On Vaccines.

December 1, 2000

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991

NIGMS Forms Bioinformatics, Computational Bio Center.

May 25, 2001

Obey Convinces House Hew Subcommittee to Cut $17 Million Control, Give It To Bioassays

June 1, 1979

Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich

April 20, 1979